ProfileGDS4718 / 201704_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 95% 85% 96% 95% 95% 97% 95% 96% 95% 96% 95% 96% 98% 93% 95% 95% 97% 95% 97% 96% 96% 96% 96% 96% 98% 96% 96% 96% 97% 94% 96% 95% 96% 95% 91% 94% 96% 96% 83% 95% 91% 95% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.538396
GSM549102patient 115, normal, homogenized [OPG study]10.137395
GSM549104patient 119, normal, homogenized [OPG study]8.5723185
GSM549108patient 138, normal, homogenized [OPG study]10.645596
GSM549119patient 077, normal, homogenized [OPG study]10.346195
GSM549133patient 032, cancer, homogenized [OPG study]10.189695
GSM549139patient 042, cancer, homogenized [OPG study]10.648397
GSM549099patient 107, normal, homogenized [OPG study]10.318295
GSM549109patient 139, normal, homogenized [OPG study]10.473496
GSM549110patient 046, normal, homogenized [OPG study]10.411995
GSM549114patient 063, normal, homogenized [OPG study]10.736296
GSM549122patient 082, normal, homogenized [OPG study]10.22495
GSM549134patient 033, cancer, homogenized [OPG study]10.472996
GSM549136patient 036, cancer, homogenized [OPG study]11.430698
GSM549140patient 044, cancer, homogenized [OPG study]9.6654993
GSM549111patient 047, normal, homogenized [OPG study]10.411295
GSM549113patient 057, normal, homogenized [OPG study]10.342195
GSM549132patient 031, cancer, homogenized [OPG study]10.749997
GSM549137patient 038, cancer, homogenized [OPG study]10.017295
GSM549142patient 047, cancer, homogenized [OPG study]10.279297
GSM549100patient 110, normal, homogenized [OPG study]10.559596
GSM549107patient 135, normal, homogenized [OPG study]10.621496
GSM549115patient 068, normal, homogenized [OPG study]10.727896
GSM549116patient 072, normal, homogenized [OPG study]10.551996
GSM549120patient 078, normal, homogenized [OPG study]10.582296
GSM549131patient 030, cancer, homogenized [OPG study]11.187598
GSM549118patient 074, normal, homogenized [OPG study]10.594796
GSM549129patient 027, cancer, homogenized [OPG study]10.422996
GSM549123patient 088, normal, homogenized [OPG study]10.527196
GSM549124patient 006, cancer, homogenized [OPG study]10.691497
GSM549126patient 015, cancer, homogenized [OPG study]9.8780294
GSM549128patient 025, cancer, homogenized [OPG study]10.554896
GSM549103patient 117, normal, homogenized [OPG study]10.249995
GSM549117patient 073, normal, homogenized [OPG study]10.637696
GSM549138patient 041, cancer, homogenized [OPG study]10.191995
GSM549141patient 045, cancer, homogenized [OPG study]9.3600891
GSM549130patient 028, cancer, homogenized [OPG study]9.8611894
GSM549101patient 111, normal, homogenized [OPG study]10.462796
GSM549105patient 128, normal, homogenized [OPG study]10.382896
GSM549106patient 134, normal, homogenized [OPG study]8.3869183
GSM549112patient 048, normal, homogenized [OPG study]10.345195
GSM549125patient 011, cancer, homogenized [OPG study]9.3590991
GSM549127patient 024, cancer, homogenized [OPG study]10.108295
GSM549135patient 035, cancer, homogenized [OPG study]9.2456990